Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€19.50

€19.50

12.070%
2.1
12.070%
€45.21

€45.21

 
26.04.24 / Frankfurt WKN: A2AJ8C / Symbol: ANAB / Name: AnaptysBio / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
€20.00
27.04.24
-
buy
€44.18
16.04.24
-2.01%
buy
€31.15
12.03.24
-10.08%
buy
€50.64
26.02.24
-13.71%
buy
€46.24
21.02.24
-16.67%
buy
€74.42
16.02.24
-2.73%
buy
Your prediction

AnaptysBio Inc Stock

A very strong showing by AnaptysBio Inc today, with an increase of €2.10 (12.070%) compared to yesterday's price.
We see a rather positive sentiment for AnaptysBio Inc with 7 Buy predictions and 1 Sell predictions.
With a target price of 45 € there is potential for a 130.77% increase which would mean more than doubling the current price of 19.5 € for AnaptysBio Inc.

Pros and Cons of AnaptysBio Inc in the next few years

Pros
?
M***** P*******
?
B****
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of AnaptysBio Inc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
AnaptysBio Inc 12.070% 5.978% -6.250% 3.723% 0.515% -4.412% -
Immunic Inc. 1.310% 2.507% -6.835% -24.272% -19.930% -91.020% -
NanoViricides Inc. -1.940% -0.980% -2.885% -10.619% 6.878% -70.910% -77.635%
Ocuphire Pharma Inc. 5.170% -7.927% -18.730% -67.838% -45.975% - -

Comments

Prediction Buy
Perf. (%) -2.01%
Target price 44.180
Change
Ends at 16.04.25

AnaptysBio, Inc. (NASDAQ: ANAB) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $47.00 price target on the stock.
Ratings data for ANAB provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -10.08%
Target price 31.147
Change
Ends at 12.03.25

AnaptysBio, Inc. (NASDAQ: ANAB) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $34.00 price target on the stock, up previously from $20.00.
Ratings data for ANAB provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -13.71%
Target price 50.644
Change
Ends at 26.02.25

AnaptysBio, Inc. (NASDAQ: ANAB) is now covered by analysts at BTIG Research. They set a "buy" rating and a $55.00 price target on the stock.
Ratings data for ANAB provided by MarketBeat
Show more

News

Why AnaptysBio Stock Zoomed Nearly 8% Higher This Week: https://g.foolcdn.com/editorial/images/772787/person-in-a-lab-looking-through-a-microscope.jpg
Why AnaptysBio Stock Zoomed Nearly 8% Higher This Week

Many stocks were wobbly over the past few trading days, but we can't say that about biotech AnaptysBio (NASDAQ: ANAB). The company's shares closed the week almost 8% higher in price, according to